Amgen Stock Soars Above $430 as Dow Inclusion and Valuation Spark Debate

Amgen stock has reached new heights, trading above $430 and currently sitting at $439.33 as of August 21, 2026.

This is a significant gain from its recent close, with shares increasing by 1.29 percent in the latest session.

The biotech heavyweight's strong performance has raised questions about its inclusion in the Dow Jones Industrial Average and its valuation compared to consensus targets.

As of August 21, Amgen stock trades at a price significantly above the average analyst target of $380.43, with a gap of more than 15 percent between the two figures.